Literature DB >> 8058113

Effects of taurine analogues on chloride channel conductance of rat skeletal muscle fibers: a structure-activity relationship investigation.

S Pierno1, D Tricarico, A De Luca, F Campagna, A Carotti, G Casini, D C Conte Camerino.   

Abstract

In rat skeletal muscle, taurine was proposed to interact with a low affinity binding site on sarcolemmal phospholipids near chloride channel, increasing chloride conductance (GCl). In an attempt to evaluate the structure-activity relationship between taurine and its binding site, a series of N-azacycloalkenyl analogues of taurine (A: N-(1'aza-cyclohepten-2'yl)-2-aminoethane sulfonic acid; B: N-(1'-aza-cyclopenten-2'-yl)-2-aminoethane sulfonic acid; C: N-(1'-aza-cyclohepten-2'-yl)-3-amino-propane sulfonic acid; D: N-(1'aza-cyclopenten-2'-yl)-3-aminopropane sulfonic acid) have been synthetized and tested in vitro on rat extensor digitorum longus (EDL) muscle. In spite of the presence of a bulky and lipophilic 5 or 7 membered heterocycle linked to the taurine amino group, analogues A and B determined an increase of GCl, although less potently than taurine. Also 3-amino-propane sulfonic acid (homotaurine), tested in comparison, showed less activity in increasing GCl with respect to taurine, probably for the increased distance between charged groups. Taurine analogues C and D, which differ from compounds A and B for an additional methylene group, showed much lower activity in increasing GCl. It has been reported that guanidinoethane sulfonate (GES) displaces taurine from the low affinity site on sarcolemma by only 7%. This compound, characterized by lower charge density on the guanidinium cationic head, applied in vitro on EDL muscle, show reduced taurine-like activity in increasing GCl.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058113     DOI: 10.1007/BF00170889

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  Enantiomers of clofibric acid analogs have opposite actions on rat skeletal muscle chloride channels.

Authors:  D Conte-Camerino; M Mambrini; A DeLuca; D Tricarico; S H Bryant; V Tortorella; G Bettoni
Journal:  Pflugers Arch       Date:  1988-11       Impact factor: 3.657

2.  On the repetitive discharge in myotonic muscle fibres.

Authors:  R H Adrian; S H Bryant
Journal:  J Physiol       Date:  1974-07       Impact factor: 5.182

3.  The transport of taurine in the heart and the rapid depletion of tissue taurine content by guanidinoethyl sulfonate.

Authors:  R J Huxtable; H E Laird; S E Lippincott
Journal:  J Pharmacol Exp Ther       Date:  1979-12       Impact factor: 4.030

Review 4.  Taurine in development.

Authors:  J A Sturman
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

5.  Uptake of [3H]taurine into myocardial membranes.

Authors:  F Franconi; F Martini; N Manghi; A Galli; F Bennardini; A Giotti
Journal:  Biochem Pharmacol       Date:  1981-01-01       Impact factor: 5.858

6.  The effects of taurine on pharmacologically induced myotonia.

Authors:  D Conte Camerino; A De Luca; M Mambrini; E Ferrannini; F Franconi; A Giotti; S H Bryant
Journal:  Muscle Nerve       Date:  1989-11       Impact factor: 3.217

7.  Increased membrane permeability to chloride in Duchenne muscular dystrophy fibroblasts and its relationship to muscle function.

Authors:  C N Pato; M H Davis; M J Doughty; S H Bryant; E Gruenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

8.  20,25-diazacholesterol myotonia: an electrophysiological study.

Authors:  R E Furman; R L Barchi
Journal:  Ann Neurol       Date:  1981-09       Impact factor: 10.422

9.  Phospholipid methylation and taurine content of synaptosomes from cerebral cortex of developing rat.

Authors:  P L Lleu; R J Huxtable
Journal:  Neurochem Int       Date:  1992-07       Impact factor: 3.921

10.  Positive inotropic effect of some taurine-related compounds on guinea-pig ventricular strips perfused with low calcium medium.

Authors:  F Franconi; P Failli; I Stendardi; R Matucci; F Bennardini; C Baccaro; A Giotti
Journal:  Eur J Pharmacol       Date:  1986-05-13       Impact factor: 4.432

View more
  7 in total

1.  Nuclear microanalysis of the monovalent ions distribution in the human amnion : II. Effect of taurine.

Authors:  A Guiet-Bara; M Bara; P Moretto; L Razafindrabe; Y Llabador; M Simonoff
Journal:  Amino Acids       Date:  1995-12       Impact factor: 3.520

2.  Taurine: a preventive agent of the acute ethanol depletive action on the isolated human amniotic membrane.

Authors:  A Guiet-Bara; M Bara
Journal:  Amino Acids       Date:  1995-09       Impact factor: 3.520

3.  Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine.

Authors:  A De Luca; S Pierno; A Liantonio; M Cetrone; C Camerino; S Simonetti; F Papadia; D C Camerino
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

4.  Effect of taurine supplementation on the alterations in amino Acid content in skeletal muscle with exercise in rat.

Authors:  Keisuke Ishikura; Teruo Miyazaki; Song-Gyu Ra; Shoji Endo; Yusuke Nakamura; Takashi Matsuzaka; Shumpei Miyakawa; Hajime Ohmori
Journal:  J Sports Sci Med       Date:  2011-06-01       Impact factor: 2.988

Review 5.  Taurine: the appeal of a safe amino acid for skeletal muscle disorders.

Authors:  Annamaria De Luca; Sabata Pierno; Diana Conte Camerino
Journal:  J Transl Med       Date:  2015-07-25       Impact factor: 5.531

Review 6.  Taurine and skeletal muscle disorders.

Authors:  Diana Conte Camerino; Domenico Tricarico; Sabata Pierno; Jean-François Desaphy; Antonella Liantonio; Michael Pusch; Rosa Burdi; Claudia Camerino; Bodvael Fraysse; Annamaria De Luca
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 7.  Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.

Authors:  Paola Imbrici; Antonella Liantonio; Giulia M Camerino; Michela De Bellis; Claudia Camerino; Antonietta Mele; Arcangela Giustino; Sabata Pierno; Annamaria De Luca; Domenico Tricarico; Jean-Francois Desaphy; Diana Conte
Journal:  Front Pharmacol       Date:  2016-05-10       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.